RX001

· GeneCraft Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RX001, covering 2025-04-23 to 2025-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate Safety and Tolerability of RX001 in Patients With KRAS Mutant Advanced NSCLC [Phase 1]